Rubius Therapeutics begins dosing in phase 1/2 trial of RTX-224 for solid tumors
January 13 2022 - 9:25AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Rubius Therapeutics (NASDAQ:RUBY)
Historical Stock Chart
From Apr 2024 to May 2024
Rubius Therapeutics (NASDAQ:RUBY)
Historical Stock Chart
From May 2023 to May 2024